Full-Time

Lead Manufacturing Technician

Confirmed live in the last 24 hours

Revance

Revance

501-1,000 employees

Biotechnology company for aesthetic solutions

Compensation Overview

$37.26 - $51.27Hourly

Mid, Senior

Newark, CA, USA

5 days/week onsite

Category
Bioinformatics
Biology Lab & Research
Biology & Biotech
Requirements
  • Bachelor’s degree & 4 years’ directly related experience; OR
  • Associate’s degree & 6 years’ directly related experience; OR
  • High school diploma / GED & 8 years’ directly related experience
Responsibilities
  • Perform routine procedures following written instructions (SOPs, batch records, solution documents, protocols, etc.) while operating in a controlled GMP environment and serves as the lead in these activities.
  • Works in compliance with established internal and external control procedures.
  • Represent the department in cross-functional meetings, equipment qualifications and provide feedback to area management.
  • Provides technical support for any process-related issues or escalations and works with Area Management for resolution.
  • Responsible for revising and originating production records, standard operating procedures, protocols and reports; initiates and closes out Deviation Reports, Change Requests and CAPAs on time.
  • Drives Drug Product process improvement initiatives including, but not limited to, performing Risk Assessments and the introduction, modification, or qualification of new or existing Drug Product processes.
  • Train and mentor new manufacturing staff on procedures, aseptic techniques, equipment and trouble-shooting skills.
  • Work with area management to perform initial review of in-process and completed documents for accuracy and to make sure batch records are turned in to area management within specified days of completion.
  • Coordinate with Quality Control, Facilities, Materials Management, Quality Assurance, Validation and to execute and complete production-related activities.
Desired Qualifications
  • Bachelor’s degree or above in biological sciences, chemical engineering or related discipline
  • 5 years’ experience with pharmaceutical or biotechnology manufacturing processes; or equivalent education, training and experience
  • Aseptic technique, cleanroom gowning and extensive knowledge of Good Manufacturing Practices (GMP).
  • Demonstrates ability to interact with senior management.
  • Hands-on experience with automated filling/capping machine, and Lyophilizer.
  • Good analytical skills to interpret manufacturing data and understand production problems.
  • Experience with process development, transfer and optimization.
  • Hands-on experience with aseptic fill finish operation.
  • Experience with execution of validation protocols.
  • Experience working with potent/toxic agents.
  • Excellent communications skills and good attention to detail.
  • Ability to work in fast paced, dynamic, team environment.
  • Ability to lift 25 pounds and stand for extended periods of time.
  • Flexibility in job responsibilities and scheduling is encouraged to meet business needs.
  • Ability to handle multiple projects at one time.
  • Basic knowledge of MS Office (Word, Excel, Outlook, PowerPoint and Project).

Revance Therapeutics, Inc. specializes in biotechnology with a focus on aesthetic and therapeutic solutions. The company primarily offers neuromodulators and dermal fillers, which are popular for minimally invasive cosmetic procedures. Neuromodulators, like botulinum toxin type A, help reduce wrinkles and treat muscle movement disorders, while dermal fillers restore volume and smooth facial lines. Revance is also exploring therapeutic uses for its products to enhance patient experiences in treating muscle movement and pain disorders. Additionally, the company has expanded into the fintech sector with the acquisition of HintMD, a platform that simplifies payment processes for aesthetic practices. This integration allows Revance to offer a comprehensive suite of services to support aesthetic practitioners. Unlike its competitors, Revance focuses on differentiated products and improved patient outcomes, aiming to lead the premium aesthetics market.

Company Size

501-1,000

Company Stage

IPO

Headquarters

Nashville, Tennessee

Founded

1999

Simplify Jobs

Simplify's Take

What believers are saying

  • Revance's collaboration with Dermata could revolutionize botulinum toxin delivery.
  • The acquisition of HintMD enhances payment processes, boosting customer satisfaction.
  • Alpine Associates' $21.61 million investment shows strong investor confidence.

What critics are saying

  • A class action lawsuit for alleged securities fraud could harm Revance's reputation.
  • Evolus's targeting of younger demographics may capture market share from Revance.
  • Minimum purchase obligations under the Distribution Agreement pose financial risks.

What makes Revance unique

  • Revance focuses on innovative aesthetic and therapeutic solutions in the biotechnology sector.
  • The company integrates fintech solutions to streamline payment processes for aesthetic practices.
  • Revance is developing needle-free botulinum toxin delivery systems with Dermata.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Unlimited Paid Time Off

401(k) Company Match

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

1%

1 year growth

-1%

2 year growth

6%
Finimize
Mar 5th, 2025
Evolus Celebrates Strong Demand For Jeuveau Wrinkle Treatment

Evolus has strategically targeted a younger audience with its wrinkle treatment Jeuveau, setting itself apart from competitors like Revance and AbbVie, which usually focus on clients in their 40s.

GlobeNewswire
Feb 4th, 2025
RVNC INVESTOR ALERT: Kirby McInerney LLP Notifies Revance Therapeutics, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit

In addition, under the Distribution Agreement, Revance is required to meet certain minimum purchase obligations and certain minimum expenditure requirements and either party may terminate the Distribution Agreement in the event of "a material breach by the other party."

PR Newswire
Jan 31st, 2025
Revance Stockholders Urged To Tender Their Shares In Support Of Crown Transaction By The February 4Th Deadline

Crown offer of $3.65 per share is the only offer available to Revance stockholders. Crown offer unanimously approved by the Revance Board of Directors. Teoxane withdraws its previous proposal, says it will tender its 6.2% stake in Revance into Crown tender

Bizjournals
Jan 30th, 2025
Revance Therapeutics to Go Private at $3.65

Revance Therapeutics is set to go private with Crown Laboratories by Feb. 6. Crown has increased its offer to $3.65 per share, a 17% rise from the previous $3.10 offer. The deal, endorsed by Revance's board, is the only fully-financed offer available. The initial $6.66 offer was paused due to a breach with Teoxane, but a settlement has been reached. Revance's shares were trading at $3.63, with a 52-week range of $2.30-$7.56. The offer is valid until Feb. 4.

Teknovation
Jan 27th, 2025
News & Notes | Acting Administrator Of National Nuclear Security Administration Has Oak Ridge Ties

From Washington, DC but with Oak Ridge ties: Teresa Robbins has been named as the Acting Administrator of the National Nuclear Security Administration (NNSA). Prior to this, she served as... The post News Notes | Acting Administrator of National Nuclear Security Administration has Oak Ridge ties appeared first on Teknovation.biz.